Stockreport

European advisory group backs ViiV's cabotegravir and rilpivirine regimen in HIV [Seeking Alpha]

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF The European Medicines Agency's advisory group CHMP hasadopted a positive opinionViiV Healthcare is the HIV-focused joint venture between GlaxoSmithKline(NYSE:GSKPFEOTCP [Read more]